Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Announces 2024 Interim Results 2024-08-28 17:44
Achieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical 2024-08-28 16:40
GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients 2024-08-27 22:28
Keymed Biosciences Announces Interim Results for First Half of 2024 2024-08-27 21:10
YolTech Announces Licensing Agreement with Salubris for the Development and Commercialization of YOLT-101 in Mainland China 2024-08-27 18:30
Mabwell Announces CDE Approval to Initiate Phase III Clinical Trial of 9MW2821 for Urothelial Carcinoma in Combination with PD-1 Inhibitor 2024-08-26 22:00
I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference 2024-08-26 19:00
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC to Initiate Phase III Clinical Trial for the Treatment of Cervical Cancer 2024-08-23 22:00
CanariaBio Inc Announces Enrollment Completion of randomized Phase 2 study of Oregovomab in combination with chemotherapy as neo-adjuvant treatment of patients with Advanced Ovarian Cancer 2024-08-23 20:00
GenFleet Announces the First Approval of a KRAS G12C Inhibitor in China for Treatment of Advanced Non-small Cell Lung Cancer Patients Harboring KRAS G12C Mutation 2024-08-23 19:30
Corina Intrauterine Drug-Eluting System approved in China as a novel treatment for patients with moderate-to-severe intrauterine adhesions (IUA) 2024-08-23 18:45
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program 2024-08-22 21:30
Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer 2024-08-22 21:00
Ractigen Therapeutics Announces U.S. FDA Orphan Drug Designation (ODD) granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy 2024-08-22 20:00
YolTech Therapeutics Administers First Patient Dose in IIT of YOLT-203, the World's First In Vivo Gene Editing Therapy for PH1 2024-08-22 18:00
WuXi Biologics Reports Solid 2024 Interim Results 2024-08-21 23:46
GenScript Launches Global Philanthropy Platform: The GenTeer Program 2024-08-21 09:40
CARsgen Announces Enrollment Completion in China GC/GEJ Pivotal Phase II Clinical Trial of the First-in-class Claudin18.2 CAR T (Satri-cel) 2024-08-19 20:50
Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform is Officially Launched 2024-08-16 06:00
Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program 2024-08-13 07:46
1 8 9 10 11 12 222